Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/medication-monitoring-for-people-with-dementia-in-care-homes-the-3aY66366sN
References (142)
-
Cheryl Vigen, Wendy Mack, Richard Keefe, M. Sano, D. Sultzer, S. Stroup, K. Dagerman, John Hsaio, Barry Lebowitz, Constantine Lyketsos, Pierre Tariot, Ling, Zheng, Lon Schneider (2011)
Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD.The American journal of psychiatry, 168 8
-
D. Sultzer, S. Davis, P. Tariot, K. Dagerman, B. Lebowitz, C. Lyketsos, R. Rosenheck, J. Hsiao, J. Lieberman, L. Schneider (2008)
Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial.The American journal of psychiatry, 165 7
-
L. Thabane, Jinhui Ma, R. Chu, Ji Cheng, A. Ismaila, L. Rios, Reid Robson, M. Thabane, L. Giangregorio, C. Goldsmith (2010)
A tutorial on pilot studies: the what, why and howBMC Medical Research Methodology, 10
-
G. Montesi, A. Lechi (2009)
Prevention of medication errors: detection and audit.British journal of clinical pharmacology, 67 6
-
(2008)
Review of Health and Social Care Burdens, Lifting the Burdens Task Force -
T. Harris, I. Carey, Sunil Shah, S. DeWilde, D. Cook (2012)
Antidepressant prescribing in older primary care patients in community and care home settings in England and Wales.Journal of the American Medical Directors Association, 13 1
-
S. Olsen, G. Neale, Kate Schwab, B. Psaila, Tejal Patel, E. Chapman, C. Vincent (2007)
Hospital staff should use more than one method to detect adverse events and potential adverse events: incident reporting, pharmacist surveillance and local real-time record review may all have a placeQuality and Safety in Health Care, 16
-
A. Thompson, S. Hetrick, M. Alvarez-Jimenez, A. Parker, Michaela Willet, F. Hughes, Maria Gariup, David Gomez, P. McGorry (2011)
Targeted Intervention to Improve Monitoring of Antipsychotic-Induced Weight Gain and Metabolic Disturbance in First Episode PsychosisAustralian and New Zealand Journal of Psychiatry, 45
-
Health Service Commissioner for England
Care and Compassion? Report of the Health Service Ombudsman on ten investigations into NHS care of older people, -
D. Thompson (2005)
British National Formulary (BNF) -
D. Mant (2008)
A Framework for Developing and Evaluating a Monitoring Strategy -
(2013)
Report of the Mid Staffordshire NHS Foundation Trust Public Inquiry: Executive Summary. House of Commons, London, UK, The Stationery Office -
J. Schroll, E. Maund, P. Gøtzsche (2012)
Challenges in Coding Adverse Events in Clinical Trials: A Systematic ReviewPLoS ONE, 7
-
(2005)
NCC MERP: The First Ten Years “Defining the Problem andDeveloping Solutions”. United States Pharmacopia, Rockville,Maryland -
Topic 2c Report 2c. Screening For Metabolic Side Effects of Antipsychotic Drugs in Patients Treated by Assertive Outreach Teams: Supplementary Audit
-
(1996)
ICH Harmonised Tripartite Guideline for Good Clinical Practice -
I. Katz, P. Deyn, J. Mintzer, A. Greenspan, Young Zhu, H. Brodaty (2007)
The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta‐analysis of 4 placebo‐controlled clinical trialsInternational Journal of Geriatric Psychiatry, 22
-
M. Shanyinde, R. Pickering, M. Weatherall (2011)
Questions asked and answered in pilot and feasibility randomized controlled trialsBMC Medical Research Methodology, 11
-
Safety in Doses: Medication Safety Incidents in the NHS
-
Shoba Iyer, V. Naganathan, A. McLachlan, D. Conteur (2008)
Medication Withdrawal Trials in People Aged 65 Years and OlderDrugs & Aging, 25
-
C. Ballard, J. Waite (2002)
The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.The Cochrane database of systematic reviews, 1
-
L. Schneider, K. Dagerman, Philip Insel (2005)
Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.JAMA, 294 15
-
J. Gurwitz, T. Field, James Judge, P. Rochon, L. Harrold, Cynthia Cadoret, Monica Lee, K. White, Jane Laprino, Janet Erramuspe-Mainard, M. Deflorio, Linda Gavendo, J. Auger, D. Bates (2005)
The incidence of adverse drug events in two large academic long-term care facilities.The American journal of medicine, 118 3
-
J. Nelson, D. Devanand (2011)
A Systematic Review and Meta‐Analysis of Placebo‐Controlled Antidepressant Studies in People with Depression and DementiaJournal of the American Geriatrics Society, 59
-
G. Lancaster, S. Dodd, P. Williamson (2004)
Design and analysis of pilot studies: recommendations for good practice.Journal of evaluation in clinical practice, 10 2
-
C. Ballard, M. Hanney, Megan Theodoulou, Simon Douglas, R. McShane, K. Kossakowski, Randeep Gill, E. Juszczak, Ly-Mee Yu, R. Jacoby (2009)
The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trialThe Lancet Neurology, 8
-
C. Ballard, J. Waite, J. Birks (2006)
Atypical antipsychotics for aggression and psychosis in Alzheimer's diseaseCochrane Database of Systematic Reviews
-
J. Higgins, D. Altman (2008)
Assessing Risk of Bias in Included Studies -
E. Heeley, J. Riley, D. Layton, L. Wilton, S. Shakir (2001)
Prescription-event monitoring and reporting of adverse drug reactionsThe Lancet, 358
-
H. Hansluwka (1992)
Measuring health. A review of quality of life measurement scales: by Ann BowlingSocial Science & Medicine, 34
-
(1999)
User's Guide to Dependency measures in Elderly People -
K. Hill, Rohan Wee (2012)
Psychotropic Drug-Induced Falls in Older PeopleDrugs & Aging, 29
-
M. Nosè, M. Mazzi, Eleonora Esposito, Marco Bianchini, Paola Petrosemolo, G. Ostuzzi, M. Tansella, C. Barbui (2010)
Adverse effects of antipsychotic drugs: survey of doctors’ versus patients’ perspectiveSocial Psychiatry and Psychiatric Epidemiology, 47
-
M. Arain, M. Campbell, C. Cooper, G. Lancaster (2010)
What is a pilot or feasibility study? A review of current practice and editorial policyBMC Medical Research Methodology, 10
-
J. Lewis, B. Strom, A. Localio, D. Metz, J. Farrar, R. Weinrieb, Lisa Nessel, C. Brensinger, S. Kimmel (2008)
Moderate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicityPharmacoepidemiology and Drug Safety, 17
-
J. Talbot, M. Keisu, L. Ståhle (2012)
Clinical Trials: – Collection of Safety Data and Establishing the Adverse Drug Reaction Profile -
M. Steinman, S. Handler, J. Gurwitz, G. Schiff, K. Covinsky (2011)
Beyond the Prescription: Medication Monitoring and Adverse Drug Events in Older AdultsJournal of the American Geriatrics Society, 59
-
David Taylor, C. Paton, S. Kapur (2009)
The Maudsley Prescribing Guidelines -
D. Healy, A. Herxheimer, D. Menkes (2006)
Antidepressants and Violence: Problems at the Interface of Medicine and LawPLoS Medicine, 3
-
T. Andrew, K. Milinis, G. Baker, U. Wieshmann (2012)
Self reported adverse effects of mono and polytherapy for epilepsySeizure, 21
-
(1999)
Crichton Royal Behavioural Rating Scale. User's Guide to Dependency measures in Elderly People. Social Services Monographs -
Lifting the Burdens Task Force
-
J. Day, G. Wood, Mike Dewey, R. Bentall (1995)
A Self-Rating Scale for Measuring Neuroleptic Side-EffectsBritish Journal of Psychiatry, 166
-
British National Formulary (BNF)
British Medical Association and the Royal Pharmaceutical Society of Great Britain, London, UK, -
M. Petrovic T. Declercq
Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and neuropsychiatric symptoms in elderly patients with dementia,Cochrane Database of Systematic Reviews
-
R. Groves (2006)
Nonresponse Rates and Nonresponse Bias in Household SurveysPublic Opinion Quarterly, 70
-
(2011)
Adverse events and nurseled medication monitoring -
A. Zermansky, D. Alldred, D. Petty, D. Raynor (2007)
Striving to recruit: the difficulties of conducting clinical research on elderly care home residentsJournal of the Royal Society of Medicine, 100
-
D. Allen, D. Hughes (2002)
Expanded nursing roles: different occupational perspectives -
(2011)
Care and Compassion? Report of the Health Service Ombudsman on ten investigations into NHS care of older people Parliamentary and Health Service Ombudsman, The Stationery Office -
J. Brown (1997)
Prescription drug use in nursing homes -
N. Pratt, E. Roughead, E. Ramsay, A. Salter, P. Ryan (2011)
Risk of Hospitalization for Hip Fracture and Pneumonia Associated with Antipsychotic Prescribing in the ElderlyDrug Safety, 34
-
D. Devanand, G. Pelton, Karine Cunqueiro, H. Sackeim, K. Marder (2011)
A 6‐month, randomized, double‐blind, placebo‐controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 26
-
Tom Smith (2011)
Antipsychotics in dementia--mortality risks and strategies to reduce prescribing.Evidence-based mental health, 14 2
-
Topic 6a. Assessment of the Side Effects of Depot Antipsychotics
-
Ruth McDonald, Justin Waring, Stephen Harrison, Kieran Walshe, R. Boaden (2005)
Rules and guidelines in clinical practice: a qualitative study in operating theatres of doctors’ and nurses’ viewsQuality and Safety in Health Care, 14
-
(2013)
Development and clinical gains of nurse-led medication profiles -
S. Jordan (2002)
Managing adverse drug reactions: an orphan task.Journal of advanced nursing, 38 5
-
M. Christensen, Andreas Lundh (2016)
Medication review in hospitalised patients to reduce morbidity and mortality.The Cochrane database of systematic reviews, 2
-
S. Jordan, A. Watkins, M. Storey, Steve Allen, C. Brooks, I. Garaiová, M. Heaven, Ruth Jones, S. Plummer, I. Russell, C. Thornton, G. Morgan (2013)
Volunteer Bias in Recruitment, Retention, and Blood Sample Donation in a Randomised Controlled Trial Involving Mothers and Their Children at Six Months and Two Years: A Longitudinal AnalysisPLoS ONE, 8
-
T. Gandhi, S. Weingart, J. Borus, A. Seger, J. Peterson, E. Burdick, D. Seger, Kirstin Shu, F. Federico, L. Leape, D. Bates (2003)
Adverse drug events in ambulatory care.The New England journal of medicine, 348 16
-
(2001)
Safety and risk management interventions in hospitals : a systematic review of the literature -
J. Gurwitz (2006)
Serious adverse drug effects--seeing the trees through the forest.The New England journal of medicine, 354 13
-
Julia Nguyen, M. Fouts, S. Kotabe, Eunice Lo (2006)
Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents.The American journal of geriatric pharmacotherapy, 4 1
-
Measuring Health: A Review of Quality of Life Measurement Scales
-
D. Allen, D. Hughes, S. Jordan, M. Prowse, S. Snelgrove (2002)
Nursing and the Division of Labour in HealthcareNursing standard (Royal College of Nursing (Great Britain) : 1987), 17 19
-
S. Jordan, J. Knight, D. Pointon (2004)
Monitoring adverse drug reactions: scales, profiles, and checklists.International nursing review, 51 4
-
Anne Cleary, F. Walsh, H. Connolly, V. Hays, B. Oluwole, E. Macken, Maura Dowling (2012)
Monitoring and documentation of side effects from depot antipsychotic medication: an interdisciplinary audit of practice in a regional mental health service.Journal of psychiatric and mental health nursing, 19 5
-
L. Hazell and S. A. W. Shakir (2006)
Under-reporting of adverse drug reactions: a systematic review,Drug Safety, 29
-
(2008)
A Randomised, Blinded, Placebo-Controlled Trial in Dementia Patients Continuing or Stopping Neuroleptics (The DART-AD Trial)PLoS Medicine, 5
-
(2008)
Information for Healthcare Professionals: Conventional Antipsychotics -
J. Deglin, A. Vallerand (1988)
Davis' Drug Guide for Nurses -
J. Jureidini, A. Tonkin (2006)
Overuse of Antidepressant Drugs for the Treatment of DepressionCNS Drugs, 20
-
N. Edwards, M. Marshall, A. Mclellan, K. Abbasi (2003)
Doctors and managers: a problem without a solution?BMJ : British Medical Journal, 326
-
(2012)
Clinical trials-collecting safety data and establishing the adverse drug reaction profile, " in Stephens'Detection and Evaluation of Adverse Drug Reactions: Principles and Practice -
E. Topinkova, J. Baeyens, J. Michel, P. Lang (2012)
Evidence-Based Strategies for the Optimization of Pharmacotherapy in Older PeopleDrugs & Aging, 29
-
T. Pavey, N. Anokye, A. Taylor, P. Trueman, T. Moxham, K. Fox, M. Hillsdon, C. Green, J. Campbell, C. Foster, N. Mutrie, Jeffrey Searle, R. Taylor (2011)
The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation.Health technology assessment, 15 44
-
A. Ralston (2003)
Side effect -
R. Proctor, Alistair Burns, H. Powell, N. Tarrier, B. Faragher, Gerald Richardson, L. Davies, B. South (1999)
Behavioural management in nursing and residential homes: a randomised controlled trialThe Lancet, 354
-
(2008)
Screening For Metabolic Side Effects of Antipsychotic Drugs in Patients Treated by Assertive Outreach Teams: Supplementary Audit -
A. Herxheimer, E. Sanz (2008)
Social, cultural and ethical aspects of drug use—changes over 40 years: a personal look backEuropean Journal of Clinical Pharmacology, 64
-
C. Seale, R. Chaplin, P. Lelliott, A. Quirk (2007)
Antipsychotic medication, sedation and mental clouding: an observational study of psychiatric consultations.Social science & medicine, 65 4
-
C Connolly (1985)
Under-reporting of adverse drug reactions.British Medical Journal (Clinical research ed.), 290
-
T. Declercq, M. Petrovic, M. Azermai, R. Stichele, A. Sutter, M. Driel, T. Christiaens (2013)
Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.The Cochrane database of systematic reviews, 3
-
S. Jordan, Billy Hardy, M. Coleman (1999)
Medication management: an exploratory study into the role of community mental health nurses.Journal of advanced nursing, 29 5
-
R. Robinson (1961)
Some problems of clinical trials in elderly people.Gerontologia clinica, 3
-
A. Quirk, R. Chaplin, S. Hamilton, P. Lelliott, C. Seale (2013)
Communication about adherence to long-term antipsychotic prescribing: an observational study of psychiatric practiceSocial Psychiatry and Psychiatric Epidemiology, 48
-
R. Grol (2001)
Improving the quality of medical care: building bridges among professional pride, payer profit, and patient satisfaction.JAMA, 286 20
-
S. Brenner, A. Detz, Andrea López, C. Horton, U. Sarkar (2012)
Signal and noise: applying a laboratory trigger tool to identify adverse drug events among primary care patientsBMJ quality & safety, 21
-
L. Caplan, L. Haverhals (2012)
Barriers and facilitators for preventing adverse drug reactions of long latency: a qualitative study.The International journal of risk & safety in medicine, 24 2
-
The Scientific World Journal -
C. Foster (1994)
International ethical guidelines for biomedical research involving human subjectsJournal of Medical Ethics, 20
-
A. Spinewine, K. Schmader, N. Barber, C. Hughes, K. Lapane, C. Swine, J. Hanlon (2007)
Appropriate prescribing in elderly people: how well can it be measured and optimised?The Lancet, 370
-
R. Romeo, Martin Knapp, J. Hellier, M. Dewey, C. Ballard, R. Baldwin, P. Bentham, A. Burns, C. Fox, C. Holmes, C. Katona, C. Lawton, J. Lindesay, G. Livingston, N. McCrae, E. Moniz-Cook, J. Murray, Shirley Nurock, J. O'Brien, M. Poppe, Alan Thomas, R. Walwyn, K. Wilson, Sube Banerjee (2013)
Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trialBritish Journal of Psychiatry, 202
-
C. Coupland, P. Dhiman, Garry Barton, R. Morriss, Antony Arthur, Tracey Sach, J. Hippisley-Cox (2011)
A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database.Health technology assessment, 15 28
-
Sube Banerjee, J. Hellier, R. Romeo, Michael Dewey, Martin Knapp, C. Ballard, R. Baldwin, P. Bentham, C. Fox, C. Holmes, C. Katona, C. Lawton, J. Lindesay, G. Livingston, N. McCrae, E. Moniz-Cook, J. Murray, Shirley Nurock, M. Orrell, J. O'brien, M. Poppe, Alan Thomas, R. Walwyn, K. Wilson, A. Burns (2013)
Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine.Health technology assessment, 17 7
-
Sunil Shah, I. Carey, T. Harris, S. DeWilde, D. Cook (2012)
Quality of prescribing in care homes and the community in England and Wales.The British journal of general practice : the journal of the Royal College of General Practitioners, 62 598
-
E. Vries, H. Prins, R. Crolla, A. Outer, G. Andel, S. Helden, W. Schlack, M. Putten, D. Gouma, M. Dijkgraaf, Susanne Smorenburg, M. Boermeester (2010)
Effect of a comprehensive surgical safety system on patient outcomes.The New England journal of medicine, 363 20
-
R. Howard, A. Avery, S. Slavenburg, S. Royal, G. Pipe, P. Lucassen, M. Pirmohamed (2007)
Which drugs cause preventable admissions to hospital? A systematic review.British journal of clinical pharmacology, 63 2
-
A. Tomlin, D. Reith, S. Dovey, M. Tilyard (2012)
Methods for Retrospective Detection of Drug Safety Signals and Adverse Events in Electronic General Practice RecordsDrug Safety, 35
-
S. Jordan, M. Coleman, Billy Hardy, D. Hughes (1999)
Assessing educational effectiveness: the impact of a specialist course on the delivery of care.Journal of advanced nursing, 30 4
-
Amy Wood-Mitchell, I. James, Anna Waterworth, A. Swann, C. Ballard (2008)
Factors influencing the prescribing of medications by old age psychiatrists for behavioural and psychological symptoms of dementia: a qualitative study.Age and ageing, 37 5
-
A. Zermansky, D. Alldred, D. Petty, D. Raynor, N. Freemantle, J. Eastaugh, P. Bowie (2006)
Clinical medication review by a pharmacist of elderly people living in care homes--randomised controlled trial.Age and ageing, 35 6
-
V. Rabenda, O. Bruyère, J. Reginster (2012)
Risk of nonvertebral fractures among elderly postmenopausal women using antidepressants.Bone, 51 4
-
(2005)
National Co-ordinating Council for Medication Error Reporting and Prevention -
D. French, R. Campbell, A. Spehar, F. Cunningham, P. Foulis (2005)
Outpatient Medications and Hip Fractures in the USDrugs & Aging, 22
-
Alzheimer’s Society. Optimising treatment and care for behavioural and psychological symptoms of dementia: a Best Practice Guide, London, Alzheimer’s Society -
J. Jalbert, L. Daiello, C. Eaton, Susan Miller, K. Lapane (2011)
Antipsychotic use and the risk of diabetes in nursing home residents with dementia.The American journal of geriatric pharmacotherapy, 9 3
-
G. Wood J. C. Day (1995)
A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients,British Journal of Psychiatry, 166
-
S. Jordan (2011)
Adverse events: expecting too much of nurses and too little of nursing research.Journal of nursing management, 19 3
-
S. Uijl, C. Uiterwaal, A. Aldenkamp, J. Carpay, J. Doelman, K. Keizer, C. Vecht, M. Krom, C. Donselaar (2006)
A cross-sectional study of subjective complaints in patients with epilepsy who seem to be well-controlled with anti-epileptic drugsSeizure, 15
-
L. Ginsburg, You-Ta Chuang, W. Berta, P. Norton, Peggy Ng, D. Tregunno, J. Richardson (2010)
The relationship between organizational leadership for safety and learning from patient safety events.Health services research, 45 3
-
(2008)
Assessment of the Side Effects of Depot Antipsychotics, The Royal College of Psychiatrists, College Centre for Quality Improvement -
B. Guthrie, C. McCowan, P. Davey, Colin Simpson, T. Dreischulte, Karen Barnett (2011)
High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practiceBMJ : British Medical Journal, 342
-
A. Forster, H. Murff, J. Peterson, T. Gandhi, D. Bates (2005)
Adverse drug events occurring following hospital dischargeJournal of General Internal Medicine, 20
-
M. Pirmohamed, Sally James, S. Meakin, C. Green, Andrew Scott, Thomas Walley, K. Farrar, Kevin Park, Alasdair Breckenridge, J. Guise, Marian McDonagh, Patricia Osterweil, P. Nygren, Benjamin Chan, M. Helfand (2004)
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patientsBMJ : British Medical Journal, 329
-
K. Lapane, C. Hughes, L. Daiello, K. Cameron, J. Feinberg (2011)
Effect of a Pharmacist‐Led Multicomponent Intervention Focusing on the Medication Monitoring Phase to Prevent Potential Adverse Drug Events in Nursing HomesJournal of the American Geriatrics Society, 59
-
D. Sackett (1979)
Bias in analytic research.Journal of chronic diseases, 32 1-2
-
M. Charny (1992)
Healthy CitiesJournal of Epidemiology and Community Health, 46
-
Office of the Inspector General
Prescription Drug use in nursing homes. In Report 2: An Inside View by Consultant Pharmacists. Dept. of Health and Human services Report No. OEI-06-96-00081, -
A. Miguel, A. Miguel, B. Marques, A. Freitas, F. Lopes, L. Azevedo, A. Pereira (2013)
Detection of adverse drug reactions using hospital databases—a nationwide study in PortugalPharmacoepidemiology and Drug Safety, 22
-
J. Higgins (2011)
Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration -
(National Co-ordinating Council for Medication Error Reporting and Prevention NCC
NCC MERP: The First Ten Years “Defining the Problem and Developing Solutions -
P. Bosboom, H. Alfonso, O. Almeida, C. Beer (2012)
Use of Potentially Harmful Medications and Health-Related Quality of Life among People with Dementia Living in Residential Aged Care FacilitiesDementia and Geriatric Cognitive Disorders EXTRA, 2
-
S. Jordan, Richard Jones, M. Sargeant (2009)
Adverse drug reactions: managing the risk.Journal of nursing management, 17 2
-
I. Testad, S. Auer, Mary Mittelman, C. Ballard, J. Fossey, Y. Donabauer, D. Aarsland, D. Aarsland (2009)
Nursing home structure and association with agitation and use of psychotropic drugs in nursing home residents in three countries: Norway, Austria and EnglandInternational Journal of Geriatric Psychiatry, 25
-
DonnaM. Fich, lamesW. Cooper, iamE. Wade, Fashp PhannD, JenniJer Waller, Ross Maclean, Marh Beers (2003)
Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.Archives of internal medicine, 163 22
-
(2012)
Patient Reported Outcomes (PROs) Workshop #1. Workshop Summary -
J. McCleery, R. Fox (2012)
Antipsychotic prescribing in nursing homesBMJ : British Medical Journal, 344
-
H. Stefan (2011)
Epilepsy in the elderly: facts and challengesActa Neurologica Scandinavica, 124
-
P. Glasziou, J. Aronson (2008)
An Introduction to Monitoring Therapeutic Interventions in Clinical Practice -
T. Masud, M. Frost, J. Ryg, L. Matzen, Marlene Ibsen, B. Abrahamsen, K. Brixen (2013)
Central nervous system medications and falls risk in men aged 60-75 years: the Study on Male Osteoporosis and Aging (SOMA).Age and ageing, 42 1
-
S. Jordan, Carol Tunnicliffe, Alan Sykes (2002)
Minimizing side-effects: the clinical impact of nurse-administered 'side-effect' checklists.Journal of advanced nursing, 37 2
-
Disciplinary Committee, John Samuels, Peter Jones (2002)
Royal Pharmaceutical Society of Great Britain -
N. Barber, D. Alldred, D. Raynor, Rebecca Dickinson, S. Garfield, Barbara Jesson, R. Lim, I. Savage, C. Standage, P. Buckle, James Carpenter, B. Franklin, M. Woloshynowych, A. Zermansky (2009)
Care homes’ use of medicines study: prevalence, causes and potential harm of medication errors in care homes for older peopleQuality & Safety in Health Care, 18
-
D. Alldred, M. Kennedy, C. Hughes, T. Chen, P. Miller (2016)
Interventions to optimise prescribing for older people in care homes.The Cochrane database of systematic reviews, 2
-
(2009)
The use of antipsychotic medication for people with dementia: time for action. A report for the Minister of State for Care Services. An Independent-Report commissioned for the Department of Health -
C. Arditi, Myriam Rège-Walther, J. Wyatt, P. Durieux, B. Burnand (2017)
Computer-generated reminders delivered on paper to healthcare professionals; effects on professional practice and health care outcomes.The Cochrane database of systematic reviews, 12
-
L. Curtis (2009)
The Prescription Drug Guide for Nurses, 23
-
H. Bootsma, L. Ricker, Y. Hekster, J. Hulsman, D. Lambrechts, M. Majoie, A. Schellekens, M. Krom, A. Aldenkamp (2009)
The impact of side effects on long-term retention in three new antiepileptic drugsSeizure, 18
-
Ruth Wightman, J. Fielding, S. Green (2011)
Audit of antipsychotic prescribing in dementia: Cambridgeshire results and lessons learnt.Psychiatria Danubina, 23 Suppl 1
-
J. Fossey, C. Ballard, E. Juszczak, I. James, N. Alder, R. Jacoby, R. Howard (2006)
Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trialBMJ : British Medical Journal, 332
- Publisher
- Wiley
- Copyright
- Copyright © 2014 Sue Jordan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- ISSN
- 2356-6140
- eISSN
- 1537-744X
- DOI
- 10.1155/2014/843621
- Publisher site
- See Article on Publisher Site
Abstract
<i>Objectives</i>. People with dementia are susceptible to adverse effects of medicines. However, they are not always closely monitored. We explored (1) feasibility and (2) clinical impact of nurse-led medication monitoring. <i>Design</i>. Feasibility “before-and-after” intervention study. <i>Setting</i>. Three care homes in Wales. <i>Participants</i>. Eleven service users diagnosed with dementia, taking at least one antipsychotic, antidepressant, or antiepileptic medicine. <i>Intervention</i>. West Wales Adverse Drug Reaction (ADR) Profile for Mental Health Medicines. <i>Outcome Measures</i>. (1) Feasibility: recruitment, retention, and implementation. (2) Clinical impact: previously undocumented problems identified and ameliorated, as recorded in participants’ records before and after introduction of the profile, and one month later. <i>Results</i>. Nurses recruited and retained 11 of 29 eligible service users. The profile took 20–25 minutes to implement, caused no harm, and supplemented usual care. Initially, the profile identified previously undocumented problems for all participants (mean 12.7 (SD 4.7)). One month later, some problems had been ameliorated (mean 4.9 (3.6)). Clinical gains included new prescriptions to manage pain (2 participants), psoriasis (1), Parkinsonian symptoms (1), rash (1), dose reduction of benzodiazepines (1), new care plans for oral hygiene, skin problems, and constipation. <i>Conclusions</i>. Participants benefited from structured nurse-led medication monitoring. Clinical trials of our ADR Profile are feasible and necessary.
Journal
The Scientific World JOURNAL – Wiley
Published: Feb 23, 2014